Peter Jarzyna

Background

About Peter Jarzyna

Pharmacist with Ph.D. in Pharmaceutical Chemistry (Focus: Immuno-Oncology, new (nontoxic) preconditioning compounds/regimens prior to cell therapies, Regenerative Medicine, iPS, Formulation Development, Tumor Pharmacology/Imaging) Formulation development √ Small molecules (injectables and oral formulations; GLP/GMP; 3 years) Perennial experience in preclinical oncology (15 years) and regenerative medicine (4 years) including animal studies √ Regenerative Medicine √ Cancer pharmacology √ Imaging (MRI, optical imaging) √ Nanomedicine (drug delivery using nanoemulsions, liposomes, PLGA nanoparticles) √ Formulation development (innovative drug delivery systems) √ Establishment of mouse tumor models (orthotopic, subcutaneous) √ Writing of SOPs for nanoparticle synthesis and testing (imaging, cell culture, ICP-MS) Experience in preclinical nanoparticle development for diabetes mellitus research (one year) √ Spleen cell isolation (mouse) for growth assays in the context of formulation testing √ Writing of SOPs with regard to in vitro testing of nanoparticles (HPLC protocols) √ INTERCULTURAL COMPETENCE including STAFF TRAINING/LEADERSHIP function (USA) √ INTERNATIONAL EXPERIENCE (USA; 11 years) √ Ability to quickly familiarize oneself with new working fields √ PROVEN TRACK RECORD of successfully planning, coordinating and finalizing large-scale in vivo animal studies in a team - GOAL- Seeking connections in the field of Immuno-Oncology, preconditioning prior to cell therapy, Regenerative Medicine and iPS cells/technology